Table 2 Descriptions of the variables used
From: Determinants of new drugs prescription in the Swiss healthcare market
Variables | Share in % (if not specified differently) | |
|---|---|---|
Study | Switzerland | |
Observed prescriptions (599,308 unique values) | ||
Generic drugs | 19.30 | n.a.a |
Rx | 78.12 | n.a. |
Age (mean) | 14.59 | n.a. |
Markets (328 unique values) | ||
Number of treated patients (mean) | 7054 | n.a. |
Yearly treatment cost (mean) | 469 | n.a. |
HHI (mean) | 0.56 | n.a. |
Number of drugs in the market (mean) | 18.5 | n.a. |
Number of active substances (ATC 5th level) (mean) | 2.97 | n.a. |
Patients (100,000 unique values) | ||
Age = 0-19 | 19.6 | 21.7 |
Age = 20-39 | 21.6 | 27.0 |
Age = 40-59 | 28.7 | 35.1 |
Age = 60-79 | 23.5 | 11.6 |
Age = 80+ | 6.7 | 4.6 |
Male | 43.1 | 49.0 |
Deductible >400 | 34.5 | n.a. |
Co-morbidity index (ATC 3rd level) (mean) | 4.8 | n.a. |
Physicians (9529 unique values) | ||
General practitioner (prescriptions’ share in %) | 33.30 | n.a. |
Independent specialist (prescriptions’ share in %) | 57.63 | n.a. |
Hospital (prescriptions’ share in %) | 9.07 | n.a. |
Regions (9 unique values) | ||
Aarau (patients’ share in %) | 9.79 | 19.33 |
Basel-Stadt (patients’ share in %) | 4.35 | 6.30 |
Fribourg (patients’ share in %) | 9.29 | 8.62 |
Geneva (patients’ share in %) | 24.60 | 14.62 |
Jura (patients’ share in %) | 0.81 | 2.35 |
Neuchâtel (patients’ share in %) | 6.86 | 5.72 |
Ticino (patients’ share in %) | 9.47 | 10.94 |
Vaud (patients’ share in %) | 25.88 | 22.21 |
Valais (patients’ share in %) | 8.94 | 9.90 |